SE402102B - Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper - Google Patents

Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper

Info

Publication number
SE402102B
SE402102B SE7304619A SE7304619A SE402102B SE 402102 B SE402102 B SE 402102B SE 7304619 A SE7304619 A SE 7304619A SE 7304619 A SE7304619 A SE 7304619A SE 402102 B SE402102 B SE 402102B
Authority
SE
Sweden
Prior art keywords
benzamide
pyrrolidinyl
cyclohexyl
amino
alkyl
Prior art date
Application number
SE7304619A
Other languages
English (en)
Swedish (sv)
Inventor
Jr A D Cale
C A Leonard
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of SE402102B publication Critical patent/SE402102B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7304619A 1972-04-03 1973-04-02 Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper SE402102B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24084072A 1972-04-03 1972-04-03
US34041773A 1973-03-12 1973-03-12

Publications (1)

Publication Number Publication Date
SE402102B true SE402102B (sv) 1978-06-19

Family

ID=26933765

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7304619A SE402102B (sv) 1972-04-03 1973-04-02 Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper
SE7711953A SE431868B (sv) 1972-04-03 1977-10-24 Forfarande for framstellning av n-(1-cyklohexyl-3-pyrrolidinyl)-bensamider med antiemetisk verkan
SE8302193A SE431869B (sv) 1972-04-03 1983-04-19 Forfarande for framstellning av n-(1-cyklohexyl-3-pyrrolidinyl)-bensamider med antiemetisk verkan

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE7711953A SE431868B (sv) 1972-04-03 1977-10-24 Forfarande for framstellning av n-(1-cyklohexyl-3-pyrrolidinyl)-bensamider med antiemetisk verkan
SE8302193A SE431869B (sv) 1972-04-03 1983-04-19 Forfarande for framstellning av n-(1-cyklohexyl-3-pyrrolidinyl)-bensamider med antiemetisk verkan

Country Status (9)

Country Link
JP (4) JPS5620312B2 (nl)
CA (1) CA999003A (nl)
CH (1) CH580582A5 (nl)
DK (1) DK138491B (nl)
ES (1) ES413260A1 (nl)
NL (1) NL178318C (nl)
NO (1) NO142077C (nl)
PH (1) PH15259A (nl)
SE (3) SE402102B (nl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA732296B (en) * 1972-04-03 1974-11-27 Robins Co Inc A H Method for controlling emesis with n-(1-substituted-3-pyrrolidinyl)benzamides and thiobenzamides
JPS5423113Y2 (nl) * 1974-10-08 1979-08-09
JPS5925784B2 (ja) * 1975-12-17 1984-06-21 山之内製薬株式会社 シンキナカルボンサンアミドユウドウタイノセイホウ
JPS5232815U (nl) * 1975-08-28 1977-03-08
JPS5925785B2 (ja) * 1976-01-01 1984-06-21 山之内製薬株式会社 新規なカルボン酸アミド誘導体
JPS5522699A (en) * 1979-08-10 1980-02-18 Yamanouchi Pharmaceut Co Ltd Novel 3-amino-1-benzylpyrrolidine derivative
JPS6316492U (nl) * 1986-07-18 1988-02-03
WO1995029891A1 (fr) * 1994-04-28 1995-11-09 Yamanouchi Pharmaceutical Co., Ltd. Derive de n-(3-pyrrolidinyl)benzamide
RU2355679C2 (ru) 2002-11-27 2009-05-20 Инсайт Корпорейшн Производные 3-аминопирролидина в качестве модуляторов рецепторов хемокинов

Also Published As

Publication number Publication date
DE2316644A1 (de) 1973-10-18
JPS5527905B2 (nl) 1980-07-24
SE431869B (sv) 1984-03-05
SE8302193L (sv) 1983-04-19
DE2316644B2 (de) 1977-04-28
JPS5069067A (nl) 1975-06-09
NL178318B (nl) 1985-10-01
NL7304557A (nl) 1973-10-05
JPS4913165A (nl) 1974-02-05
DK138491C (nl) 1979-04-09
SE7711953L (sv) 1977-10-24
NL178318C (nl) 1986-03-03
SE431868B (sv) 1984-03-05
JPS5069066A (nl) 1975-06-09
JPS5182261A (en) 1976-07-19
DK138491B (da) 1978-09-18
SE8302193D0 (sv) 1983-04-19
CH580582A5 (nl) 1976-10-15
JPS5620312B2 (nl) 1981-05-13
ES413260A1 (es) 1976-05-16
NO142077C (no) 1980-06-25
NO142077B (no) 1980-03-17
CA999003A (en) 1976-10-26
PH15259A (en) 1982-11-02

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE402102B (sv) Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE416176B (sv) Forfarande for framstellning av hogdoserade autibiotikatabletter
SE395460B (sv) Forfarande for framstellning av 2beta,16beta-dipiperidino-5alfa-androstaner
SE397827B (sv) Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE385005B (sv) Forfarande for framstellning av substituerade pyrrolidinmetanoler med terapeutisk verkan
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE383738B (sv) Forfarande for framstellning av sulfamoyl-bensensulfonamider med terapeutiska egenskaper
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
SE405853B (sv) Forfarande for framstellning av 2-kinoxalinkarboxamid-1,4-dioxider
NO139604C (no) Fremgangsmaate for fremstilling av tert.-butyl-4-tert.-butylperbenzoat